Product Description
PSA (Prostate Specific Antigen) Rapid Quantitative Test: -
The Finecare PSA Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare FIA System for quantitative determination of Prostate Specific Antigen (PSA) in human whole blood, serum or plasma. The test is used as an aid in diagnosis of prostatic cancer.
Technical Details 
Fast, Accurate PSA QuantificationDesigned for rapid and reliable PSA detection, Finecare PSA Rapid Quantitative Test uses lateral flow immunofluorescence technology to provide precise results in under 15 minutes. Ideal for prostate cancer screening and monitoring, its analytical sensitivity reaches 0.2 ng/mL, supporting early detection and patient management.
Seamless Compatibility and OperationEach test cassette pairs perfectly with the Finecare FIA Meter, enabling digital interpretation and simple workflow. The device operates quietly, and can be powered by AC supply or batteries, making it portable and versatile for clinical or laboratory settings. Both manual and automatic operation modes are supported.
Built-in Quality Control and Long Shelf LifeThe kit features an internal control line for reliable, real-time operation. With a shelf life of 24 months and storage temperature range of 2C to 30C, Finecare PSA tests can be stored conveniently and securely, ensuring performance consistency across multiple applications.
FAQ's of Finecare PSA (Prostate Specific Antigen) Rapid Quantitative Test:
Q: How does the Finecare PSA Rapid Quantitative Test work for detecting PSA levels?
A: The test utilizes immunofluorescence chromatographic assay technology to quantitatively measure PSA in human serum or plasma. Results are interpreted digitally when the test cassette is placed in the compatible Finecare FIA Analyzer, delivering precise and rapid readings within 15 minutes.
Q: What is the minimum sample volume required for the test, and what specimen types are accepted?
A: Only 10 L of human serum or plasma is needed per test, making it minimally invasive and suitable for both clinical and laboratory use.
Q: When should Finecare PSA Rapid Quantitative Test be used?
A: It is recommended for prostate cancer screening, monitoring PSA levels in diagnosed patients, and assessing therapeutic response. The rapid turnaround time makes it ideal for applications requiring timely, quantitative results.
Q: Where can the Finecare PSA test be stored, and what are the recommended storage conditions?
A: Store the kit at temperatures between 2C and 30C, away from direct sunlight. Ensure packaging is intact and unopened until use. The shelf life for each kit is 24 months, with the expiry date indicated on the packaging.
Q: What process should be followed to perform the test and interpret the results?
A: Begin by collecting a serum or plasma sample, add it to the test cassette, and insert into the Finecare FIA Analyzer. The built-in control line verifies the test's validity, and the digital display provides quantitative PSA results, ranging from 0.5 to 100 ng/mL.
Q: What are the key benefits of using Finecare PSA Rapid Quantitative Test?
A: This test offers high sensitivity (0.2 ng/mL), rapid results (within 15 minutes), minimal sample use, and precise quantification (>99% accuracy). Its CE marking and built-in controls ensure reliable performance in both hospital and reference laboratory environments.
Q: Is this test suitable for point-of-care use and how portable is it?
A: Yes, the test cassettes are lightweight and portable, requiring only the Finecare FIA Analyzer-which operates on AC or battery power. This makes the system ideal for point-of-care settings, outreach programs, and facilities needing mobile diagnostic solutions.